After hours on 04 Mar 2026 Healwell AI Inc. (AIDX.TO) traded at C$0.78, up 3.33% on volume of 799,633 shares on the TSX. The move follows renewed interest in AI-driven healthcare tools and the company’s strategic alliance with WELL Health Technologies. We review the AIDX.TO stock fundamentals, technicals, sector context and short-term price signals for investors watching AI healthcare plays in Canada.

AIDX.TO stock: After-hours price action and key intraday data

AIDX.TO closed the regular session at C$0.75 and rose to C$0.78 in after-hours trading on 04 Mar 2026, a 3.33% change. Intraday range was C$0.74–C$0.80, with volume 799,633 versus average volume 528,794, giving a relative volume of 1.51.

AIDX.TO stock: Fundamentals and valuation snapshot

Healwell AI (AIDX.TO) trades on the TSX in Canada with market cap about C$215.76M and shares outstanding 278,397,768. Trailing EPS is -0.23 and PE reads -3.37, reflecting losses. Key ratios: P/S 2.06, P/B 1.46, and current ratio 0.85, which signals tighter short‑term liquidity versus many healthcare peers.

AIDX.TO stock: Technicals and trading setup

Momentum indicators show mixed signals. RSI is 54.07, MACD histogram small positive, and ADX at 33.60 suggests a strong trend. Bollinger bands sit C$0.57–C$0.80 with ATR C$0.05, indicating modest intraday volatility. Short-term averages: 50‑day C$0.79, 200‑day C$1.18, leaving the stock below its long-term trend.

AIDX.TO stock: Sector context, catalysts and risks

In Healthcare, the sector average PE is 13.98 and many peers show stronger margins. Healwell’s AI focus and the WELL Health alliance are positive catalysts for adoption and revenue growth. Main risks include negative operating margins, cash per share C$0.07, and tight current ratio 0.85, which increase funding sensitivity.

AIDX.TO stock: Meyka grade, model signals and analyst context

Meyka AI rates AIDX.TO with a score of 62.14 out of 100 — Grade B — HOLD. This grade factors in S&P 500 and sector comparisons, financial growth, key metrics and analyst context. These grades are model outputs and are not guaranteed or financial advice. Independent analysts show limited coverage and no published price consensus.

AIDX.TO stock: Price targets, forecast and trading strategy

Short-term model scenarios: bear C$0.60, base C$0.85, bull C$1.40. Technical traders may use C$0.80 as near-term resistance and C$0.58 as support near the 52‑week low. Company calendar: next earnings announcement scheduled 2026-03-26. For active AI stock strategies, watch adoption metrics and cash runway.

Final Thoughts

Key takeaways on AIDX.TO stock: Healwell AI trades at C$0.78 after hours with above‑average volume, but fundamentals show negative EPS -0.23 and a current ratio 0.85, highlighting near-term funding sensitivity. Meyka AI’s forecast model projects a quarterly price of C$0.72, implying -7.10% versus the current price C$0.775; forecasts are model-based projections and not guarantees. Our price target range reflects the company’s AI healthcare opportunity balanced by execution risk: base C$0.85, bear C$0.60, bull C$1.40. Short-term traders should monitor the upcoming 2026-03-26 earnings, adoption updates from the WELL Health partnership, and volume confirmation above avgVolume 528,794. Meyka AI, an AI-powered market analysis platform, highlights that AIDX.TO stock may offer selective opportunity for investors focused on AI healthcare growth, but the company’s cash position and margin profile demand caution and active risk management.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.